Cerebral Arteriovenous Malformations (cAVMs): What Is New? by Ahmed Ganaw, Adel E. et al.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Cerebral Arteriovenous 
Malformations (cAVMs): What Is 
New?
Adel E. Ahmed Ganaw, Abdulgafoor M. Tharayil, 
Moad Ehfeda, Mohamed Hassan Alfared, Qazi Zeeshan,  
Sohel M.G. Ahmed, Ali Ayyad, Ibrahim Naemi, 
Hossam Algallie, Nissar Shaikh and Nabil Shallik
Abstract
Cerebral arteriovenous malformations (cAVMs) are rare congenital anomalies 
of cerebral blood vessels that result from maldevelopment of the capillary bed, 
permitting direct communication between cerebral arteries and veins. It usually 
occurs in the supratentorial area of the brain; however, it can occur anywhere in the 
brain and spinal cord. Most of the patients with cAVMs present with a variety of 
complaints such as seizures, intracerebral hemorrhage, headache, and progressive 
focal neurological deficit. Imaging such as CT, MRI, and angiography plays a vital 
role in diagnosis, grading, risk assessment, and posttherapeutic follow-up. The 
multidisciplinary team use three therapeutic modalities in the treatment of cAVMs. 
This chapter reviews the clinical presentations, diagnosis, classification, and treat-
ment of cAVMs.
Keywords: cerebral angiography, endovascular embolisation,  
focal neurological deficit, headache, intracerebral hemorrhage, microsurgery, 
radiosurgery, seizers
1. Introduction
Arteriovenous malformations (AVMs) are rare congenital anomalies of cerebral 
blood vessels with critical clinical implications. These anomalies may occur any-
where in the central nervous system (brain and spinal cord). It is a neurosurgical 
emergency that is characterized by abnormal vascular web, consisting of a tangle of 
dysplastic vessels (nidus) fed by arteries and drained by veins without intervening 
capillaries, generating a high flow, low resistance shunt between cerebral arteries and 
veins (Figure 1). They are a significant form of vascular malformation, with dilated 
arteries congregating from different directions and distended veins twisting from 
turbulence of shunted blood flow. This gives the pathology its radiological char-
acteristic (early venous drainage) on formal catheter-based cerebral angiography. 
Although cAVMs are considered as a congenital cerebrovascular disease, patients 
may present with intracerebral hemorrhage, convulsions, chronic headache, and 
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progressive neurological deficit. Some of them remain asymptomatic and are noticed 
only incidentally on cerebral imaging for other indications. AVMs are associated with 
a lifelong risk of intracerebral hemorrhage (ICH); therefore, these lesions necessitate 
appropriate assessment, workup, and considerations for treatment based upon many 
factors such as age, size, and location of the lesions [2–5].
2. Epidemiology
The prevalence of cAVMs is very low, and a collection of population-based 
studies from the literature estimates the incidence of cerebral AVMs at 0.69–1.32 
per 100,000. However, they are considered as an important cause of intracerebral 
hemorrhage in a young age group. Bleeding rate is almost 1% per year in previously 
unruptured arteriovenous malformations. cAVMs cause approximately 2–4% of all 
hemorrhagic strokes [2, 4, 6, 7].
They are a congenital disease that is developed from indistinguishable causes 
in developing a fetus. While numerous mechanisms of cAVM formation have been 
suggested, the heterogeneity and lack of inheritance of these pathologies make their 
exact cause to remain idiopathic. They are associated with a few syndromes, such 
as hereditary hemorrhagic telangiectasia, Wyburn-Mason syndrome, von Hippel-
Lindau disease, and Sturge-Weber syndrome [2].
Cerebral AVMs generally occur as a single lesion, and multiple lesions are observed 
only in 9% of the patients. cAVMs are equally distributed between sexes [8, 9].
Patients may present at any age, although they most commonly present in the 
second through fourth decades of life [6, 7].
3. Clinical manifestation
cAVM patients may present with a variety of clinical symptoms such as hemor-
rhage, seizure, headaches, or focal neurologic deficits. The clinical presentations 
of cAVMs depend on the patient’s age, size, location, and vascular features of the 
cAVMs. Some patients are asymptomatic at presentation and cAVMs are accidently 
discovered when imagines are performed for potentially unrelated reasons.
3.1 Hemorrhage
Hemorrhage is the most common initial presentation of cAVMs. Studies 
reported that hemorrhage is the initial presentation in 50% of patients with cAVMs. 
The risk of hemorrhagic stroke in cAVM patients is about 2–5% per year. It is fatal 
Figure 1. 
(A) Normal vasculature, arteries, and veins communicate at capillary bed. (B) cAVM direct communication 
between high-flow arterial vessels and low-resistance venous capacitance vessels. And an arteriovenous 
malformation. Steal phenomenon (blood flow through low resistance shunt (low resistance) and stealing blood 
flow from adjacent brain) [1].
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in 5–25% of all cAVM patients. Children more frequently present with intracerebral 
hemorrhage than do adults. Hypertension, previous intracerebral hemorrhage 
(ICH), AVMs with feeding artery aneurysm, AVMs with multiple arterial feed-
ers, deep-seated cAVMs, and cAVMs with limited venous drainage are associated 
with increased risk of hemorrhagic stroke. Hemorrhage begins in the lesion itself 
and then accumulates, increases in size, and produces a mass effect. Therefore, 
hemispherical lesions generate less severe syndromes in comparison with primary 
hemorrhage that originates from functioning parts of the brain. Hemorrhages in 
polar regions such as frontal, temporal, and occipital regions may cause only minor 
headache, while those in deeper structures affect vital regions packed into tiny 
spaces and produce severe neurological manifestations. Hence, patients with ICH 
may present with a wide span of presentations such as sudden severe headache, 
drop in the level of consciousness, progressive neurological deficits, hemiparesis, 
aphasia, cranial nerve palsy, visual field deficits, and coma [2, 9–11].
The type of the hemorrhage and clinical presentations depend on the location of 
cAVMs. Superficial lesions cause subarachnoid hemorrhage with low risk of cerebral 
vasospasm and the bleeding confined in local sulci, whereas lesions with deep drainage 
may vent blood in the ventricular system, causing hemohydrocephalus. Lesions embed-
ded in the brain parenchyma cause parenchymatous hemorrhage. Figure 2 [11, 13].
3.2 Seizure
Seizures are the second most common presentation of cAVMs; it occurs in 20–29% 
of patients with cAVMs at initial diagnosis. One study showed that the 5-year risk of first 
seizure was 8% (95% CI 0–20). The risk of the seizures rose to 23% in the presence of 
ICH and focal neurological deficit. The seizures are frequently observed in male patients 
with cortical lesions, especially in the frontal and temporal lobe. Large lesions (nidus 
greater than 3 cm in diameter) and superficial venous drainage are associated with 
increase in seizure frequency. Posterior fossa, coexisting aneurysms, and deep locations 
were associated with the absence of seizures. AVM may cause focal or generalized sei-
zures or both. The exact pathophysiology of the seizures is not completely understood. 
However, increased venous back pressure secondary to venous outflow obstruction may 
be involved. cAVM-related seizures may occur secondary to ICH, from the hemosiderin 
deposition, or secondary to venous hypertension, and ischemia following steal. Seizure 
control rate ranges between 49 and 85% according to approach (surgery, radiosurgery, 
or embolisation), and the highest seizure freedom has been achieved in patients with 
approved complete angiographic obliteration after radiosurgery [2, 9, 14].
Figure 2. 
(A) Axial and (B) sagittal plain CT brain of 13-year-old patient presented with sever headache; the scan 
demonstrates right parieto-occipital intra-axial hemorrhage with intra-ventricular extension. Urgent 
craniotomy was done due to deterioration of the neurological status confirming underlying AVM [12].
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3.3 Headache
Approximately 0.2% of cAVM patients present with headache and normal 
neurologic examination. The headache associated with cAVMs is incidental, 
without any specifications. Headache is the presenting symptom in nearly 15% 
of cAVM patients without evidence of rupture. Headache can be characterized as 
similar to migraines with lateralization to one side [11, 13]. The attack occurrence, 
aurae, duration, and pulsatile quality are all shared. Treatment of headache in AVM 
patients has not been studied so far. No specific medication has been exclusively 
useful in headache management. Expert opinions do not recommend using any 
vasoconstrictors in these patients as it may lead to rupture and ICH. However, there 
are limited data to support this recommendation [9].
3.4 Neurological deficit
Neurological deficit is a relatively rare presentation of cAVMs. Patients may 
present with transient, progressive, permanent, or progressive focal neurological 
deficits not secondary to ICH or seizures. Vascular steal syndrome is assumed to be 
the main reason of neurologic deficit. Moreover, recurrent ICH, local mass effect, or 
hydrocephalus may cause neurological deficits [2, 9].
4. Diagnosis of cAVMs
Diagnosis of cAVMs must include a detailed assessment of the nidus and the 
adjacent structures. Plain CT is the initial diagnostic tool for cAVM patients who 
present with one of previously mentioned clinical manifestations, while CT angiog-
raphy or digital subtraction angiography are used to locate the exact site of rupture 
in patients with ICH. Magnetic resonance imaging (MRI) is the recommended 
investigation for patients with nonhemorrhagic manifestations. Digital subtraction 
angiography is the investigation of choice for the characterization of the feeding 
arteries, nidus angioarchitecture, and draining veins and is mandatory for precise 
AVM grading and management planning [2, 4].
4.1 Computerized tomography (CT) and related techniques
CT scan is the first radiological investigation that is performed in patients 
who present with convulsions, focal neurological deficit, or clinical signs of 
ICH. Plain head CT is useful for confirming ICH or assessing abnormal suspi-
cious dilated dural veins, abnormal faint hyperdense cerebral mass, and focal 
cerebral calcification, which are alert signs for the radiologist for the possibility 
of underlying cAVMs; however, negative CT scan cannot be excluding the pres-
ence of cAVMs. Compression of the nidus by hematoma impedes CT diagnosis 
of cAVM in patients with acute ICH. Therefore, CT angiography should be done 
promptly to diagnose the underlying cAVMs. CT angiogram with intravenous 
iodinated contrast media with images acquired by bolus tracking technique is 
very helpful for maximum cerebral as well as cAVM arterial opacification. The 
CT head angiogram is used for confirming the diagnosis, assessing the cAVM 
size, site, number, and origin of feeding arteries and draining vein as well 
as the presence of associated aneurysm and site of bleeding. The high spatial 
resolution of CTA allows the generation of multiplanar reformations, maximum 
intensity projections, and volumetric reconstructions for analysis (Figures 3–5) 
[4, 16, 18].
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Figure 3. 
Plain CT head (A) and CT head angiogram (B) of young adult patient demonstrate right parietal 
parenchyma brain hemorrhage (the arrow on A image) and multiple serpiginous tortuous vascular 
malformation AVM (the arrow on the B image) [15].
Figure 4. 
Plain CT shows hyperdense tortuous structure at lateral ventricular region representing AVM [16].
Figure 5. 
CT head angiogram MIP (maximum intensity projection) axial and sagittal view (A and B respectively) 
demonstrates right occipital lobe AVM supplied mainly by right posterior cerebral artery and drained to 
straight and right transverse dural sinuses [17].
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In recent decades, the radiological equipment has showed visible development 
making us more aware of the pathophysiology of many diseases by using perfu-
sion CT and MRI scan for cAVMs to provide information regarding the blood 
flow abnormality within and around such vascular anomalies by assessing cerebral 
blood flow (CBF),  cerebral blood volume (CBV), and the mean transient time 
(MTT). Through these, we can demonstrate three different forms of extra-nidal 
parenchymal perfusion abnormalities:
1. Functional steal is characterized by redistribution of the blood flow from 
surrounding brain tissue through the arteriovenous malformation that leads 
to disturbance of normal cerebral perfusion. Patients with this phenomenon 
usually present with convulsions. CT scan shows decrease in CBV, CBF, and 
MTT as a result of sump effect from the artery supplying the arteriovenous 
malformation Figures 6 and 7.
Figure 6. 
Normal and Perfusion abnormalities diagram in cAVMs. (A) Illustrate normal brain tissue blood flow. (B) 
Illustrate the abnormal brain tissue blood flow within and adjacent to the AVM. The Black arrow represent 
functional steal region in which the blood shunted away to the nearby AVM. The red arrow representing 
ischemic steal region due to indirect collateral of the near the AVMs. The blue arrow is a brain region drained 
by high pressure veins of AVM leading to venous congestion [15].
Figure 7. 
Illustrate the effect of steal phenomenon in Brain’s AVM on adjacent brain tissue (A) and (B) CT angiograms 
demonstrate right side occipital AVM (arrows). Selected images from brain CT perfusion (C and D) shows 
high CBF (black arrows in C) and CBV (black arrows in D) in the nidus and low CBF (white arrows in C) 
and CBV (white arrows in D) in the perinidal area, suggestive of perinidal ischemia. There is no evidence of 
cerebellar ischemia on the FLAIR (E) and diffusion (F) images. CBF (arrows in G) and CBV (arrows in H) 
are low in the contralateral cerebellar hemisphere, suggestive of cerebellar diaschisis [19].
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2. Ischemic steal is characterized by a reduction in CBF and CBV with increased 
MTT in the brain parenchyma secondary to indirect collateral flow to the shunt 
from nearby arteries. These patients usually present with a focal neurological 
deficit.
3. Venous congestion is characterized by increased CBV and MTT in remote 
parts of the brain as a result of the high-pressure flow in the draining veins of 
the AVM. These patients may present with progressive neurological deficits 
[4, 15, 16, 18].
4.2 Magnetic resonance imaging (MRI) of the brain and related techniques
MRI of the brain is very sensitive for the exact determination of the cAVM 
nidus location and an associated draining vein; it also has exclusive sensitivity in 
determining remote bleeding due to these lesions. On noncontrast brain MRI, the 
cAVM nidus is seen as signal void on T2-weighted images with dilated feeding 
arteries and draining veins, and susceptibility-weighted imaging can detect the 
presence of hemosiderin component of chronic bleeding as low signal intensity. 
The ischemic and brain steal area can appear as hyperintense T2 weighted and 
FLAIR. MRA also could be used to add crucial information regarding the feeding 
arteries, draining veins, and the presence of associated aneurysm, which appear 
Could be gained from CT perfusion (CTP). The same pathophysiological infor-
mation that could be gained from CTP can also be done by MRI perfusion using 
noncontrast ALS (arterial spine labeling) technique or with the usage of contrast 
media Figures 8 and 9 [2, 4].
MRI of the brain is especially valuable in follow-up patients after treatment. 
After radiosurgery, MRI is essential to follow up regression of the nidal volume. 
While the MR angiography is very useful to characterize the venous drainage and 
other vascular features, the adjacent tissue that is exposed to the radiation field can 
be precisely observed for posttherapy edema or radiation necrosis [4, 16].
4.3 Digital subtraction angiography (DSA)
Digital subtraction angiography is the gold standard for assessment of nature 
and number of the feeding arteries, presence of flow-related aneurysms, quality of 
venous drainage, associated varices, and stenosis.
Figure 8. 
MRI brain of an adult patient T2-weighted image A and SWI (susceptibility weighted image). B demonstrates 
right temporal T2WI and DWI serpiginous hypointensity representing AVM [20].
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Two types of feeding arteries that can be identified by DSA are as follows:
1. Direct arterial feeders: they end in the AVM; it is either large cortical arteries 
or small perforator coursing through white matter or ventricles.
2. Indirect arterial feeders: they supply the AVM through small branches that 
arise from the involved but also pass to healthy brain tissue distal to AVM.
Flow-related aneurysms in the feeding arteries usually result from amplified 
shear stress and considered as an indicator of vascular friability and hemor-
rhage risk. These aneurysms may resolve following curative treatment of the 
AVM. Intranidal aneurysms are usually small, less than 3 mm, and pseudoaneu-
rysms and can be successfully treated with embolisation.
The AVM nidus may have both fistulous and glomerular compartments; the 
fistulous compartments form high-flow shunt that can be treated with endovascu-
lar therapy, while the glomerular compartments form an intervening network of 
pathological vessels and are very difficult to treat with embolisation.
Assessment of the venous part of AVM is critical and should include the 
anatomy of drainage (superficial, deep, or mixed) and characteristics of the 
venous outflow (focal stenosis, venous pouches, and sinus stenosis or occlu-
sion). Drainage into the deep venous system is associated with a high risk of 
bleeding and indicates deep location that may make surgical intervention 
difficult [2, 4].
Figure 9. 
MRI T2-weighted image A&B and MRA brain C&D images the brain demonstrate T2 weighted signal void 
serpiginous structure at left inferior parietal lobe; on MRA, images show the nidus fed by arterial feeder 
from left middle cerebral artery and drained to superficial cortical veins to left transverse sinus [16].
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5. Grading of cAVMs
Before starting the management of cAVMs, all management risks should be 
considered, starting from those associated with diagnosis, surgical intervention, 
radiotherapy, to interventional radiology. Treating physicians should also consider 
both early and late complications such as hemorrhage and convulsions. There are 
many grading systems that may help physicians to assess the risk of these com-
plications, take appropriate intervention for each patient, predict prognosis, and 
standardize patient’s evaluation for scientific study purposes [21–23].
5.1 Spetzler-Martin (S-M) grading
In 1986, Spetzler and Martin introduced the most commonly used grading scale 
for cAVMs; it uses three anatomical features of AVM (nidus size, nidus location 
relative to the eloquent brain (Figure 10), and pattern of venous drainage) to gener-
ate five cAVM grades (Table 1).
To determine S-M grade of cAVMs, size of the nidus, venous drainage, and 
eloquence of adjacent brain tissue are determined in angiography, brain CT scan, and/
or MRI of the brain. A numerical value is assigned for each category, as described in 
Table 1. The grade is derived from adding the points awarded for each category; for 
example, for grade I, the lesion would be small (less than 3 cm/1 point), in nonelo-
quent region (0 point), and have only superficial drainage (0 point) (Figure 11); 
therefore, excision of such lesion would be complete, minimally invasive, and 
associated with low surgical complications. Whereas for grade V, the lesion would be 
large (more than 6 cm/3 points), sited within or immediately close to eloquent brain 
Figure 10. 
The anatomic areas considered neurologically eloquent. (A) Deep eloquent area (hypothalamus, thalamus, 
brain stem, and cerebellar peduncle). (B) Eloquent area in cerebral cortex (sensory-motor, primary visual, 
and language area) [19].
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(1 point), and venous drainage would drain into deep venous system (Figure 12), so 
excision of such lesion is extremely difficult and associated with significant risk of 
bleeding and surgical morbidity and mortality. Moreover, obliteration of large cAVMs 
leads to sudden increase in perfusion, which leads to vasogenic edema or hemorrhage 
(normal perfusion pressure break through phenomenon). There are certain lesions 
that should not be considered for surgery such as large AVM that invades eloquent 
critical area or diffuse nidus that involves crucial structure such as hypothalamus or 
brain stem (Figure 13), so the surgical resection of such lesions would necessarily 
be associated with significant neurological deficit or death. These AVMs are graded 
under separate category (grade VI) and considered as inoperable AVM [22, 23].
The S-M grading scale was introduced to predict the outcome of surgical resec-
tion but can also be used to predict the radiosurgical outcome. Lower grades (grades 
I and II) are associated with a good result and less postoperative neurological deficit 
in comparison with grades IV and V [21–23].
Multiple retrospective studies showed that rates of poor outcome were highly 
correlated with S-M grade. Precisely, rates of poor outcome were calculated as 
follows: S-M grade I = 4% (95% CI, 2–7), S-M grade II = 10% (95% CI, 7–13), S-M 
Figure 11. 
Grade I AVM; (A) Vertebral angiograms. (B) Anteroposterior view cerebellar AVM less than 3 cm (1 point), 
superficial on cerebellar cortex (0 point), superficial drainage (through superficial cerebellar hemisphere 
veins–arrows: 0 point) [19].
Size of cAVM Point
0-3 cm 1
3.1-6 cm 2
>6 cm 3
Location of cAVM (eloquence area)
No 0
Yes 1
Venous drainage
Superficial 0
Deep 1
Table 1. 
Spetzler-Martin (S-M) grading scale is used to make decisions about treatment risks.
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grade III = 18% (95% CI, 15–22), S-M grade IV = 31% (95% CI, 25–37), and S-M 
grade V = 37% (95% CI, 26–49). These results prove that microsurgical resection 
is suitable for low-grade cAVMs (S-M grades I and II), whereas surgical resection 
of high-grade cAVMs (S-M grades IV and V) is associated with a high risk of poor 
patient outcome. Lawton and Davies et al. subcategorized grade III into three 
groups based on a specific combination of the same anatomical features (size, loca-
tion, and venous drainage) to improve prediction of treatment outcome:
Group 1: Patients with S-M grade III cAVMs (a combination of small size, elo-
quent location, and deep venous drainage) have surgical outcomes similar to those 
of S-M grades I and II.
Figure 12. 
Grade VAVM; (A) Carotid angiogram, arterial phase. (B) Venous phase, AVM greater than 6 cm (3 points), 
situated in corpus callosum with a deep thalamic component (eloquent: 1 point), draining into a hugely dilated 
internal cerebral vein (deep drainage–arrow 1 point) [19].
Figure 13. 
Grade IV AVM (inoperable AVM), (A) Vertebral angiogram, anteroposterior view. (B) Lateral view, 
arterial phase this lesion fed by multiple vessels from rostral basilar artery, surrounding and invading the 
mesencephalon [19].
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Group 2: Patients with S-M grade III cAVMs (a combination of medium size, 
noneloquent location, and deep venous drainage) have a poor surgical outcome 
similar to that of S-M grades IV and V.
Group 3: Patients with S-M grade III cAVMs (a combination of medium size, 
eloquent location, and superficial venous drainage) have a poor surgical outcome 
similar to that of S-M grades IV and V [23].
Supplementary grading scale to traditional S-M grading scale was proposed in 
2010 to enhance its predictive power for predicted outcomes after surgical resec-
tion of cAVMs. This supplemental scoring system added three factors that affect 
patient’s outcome (age, hemorrhagic presentation, and nidus configuration) 
(Table 2). The supplementary grading scale named Lawton-Young supplementary 
grading scale has been authorized in a separate cohort of 1009 patients [21, 23].
6. Treatment of cAVMs
Complete resection or obliteration of the nidus and AV shunt is considered as 
the treatment of choice of cAVMs. Incomplete nidal resection does not decrease 
hemorrhage risk. However, There are few reports of partial resection may improve 
neurological symptoms in patients who have neurological symptoms related to 
hemodynamic. There are three complementary therapeutic techniques that have been 
developed to achieve these goals (microsurgery ± embolization, stereotactic radio-
surgery, and embolisation). The treatment plans of cAVMs should be carefully taken 
by a multidisciplinary team of knowledgeable and skilled physicians. They should 
take the size, location, and vascular features of the AVM in consideration. Moreover, 
risks of significant complications such as short- and long-term hemorrhage risk, 
feasibility, associated aneurysm, patient’s age, risks of intervention, availability of 
interventional radiologist, and size and compactness of the nidus should be assessed. 
The short- and long-term hemorrhage risk is associated with a history of raptured 
cAVM, patient age, AVM location, size, and vascular morphological features [23–25].
Children and young adults have a long life expectancy, and the risk of intrace-
rebral hemorrhage (ICH) is gradually increasing over the years. Therefore, curative 
therapy and complete obliteration are recommended whenever possible, while 
conservative treatment may be considered for elderly patients. The cumulative risk 
of hemorrhage can be calculated by the formula: lifetime risk of hemorrhage = 1 – 
(1 − P) × N (N is the expected years of life remaining, and P is the annual probabil-
ity of hemorrhage). Another more straightforward formula is as follows: lifetime 
risk of hemorrhage = 105-patient’s age in years.
Size of cAVM Point Patient’s age
0-3 cm 1 <20
3.1-6 cm 2 20-40
>6 cm 3 >40
Location of cAVM (eloquence area) Compactness
No 0 Yes
Yes 1 No
Venous drainage Bleeding
Superficial 0 Yes
Deep 1 No
Table 2. 
Supplementary Spetzler-Martin or Lawton-Young cAVM grading scale.
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6.1 Microsurgery
Craniotomy and surgical resection of cAVMs were first introduced in the 1920s, 
where the outcomes were inferior. The development of angiography played an 
essential role in understanding vascular anatomy and hemodynamics of AVM 
lesions. The introduction of microsurgery and bipolar diathermy has resulted in 
significant improvement of morbidity and mortality in comparison to the early 
known surgical resections. Microsurgical excision of cAVMs is considered as the 
most efficient approach as it offers the best chance of immediate cure and elimi-
nates morbidity and mortality associated with its potential rupture. Before taking 
patients to the operating theater for surgical resection, preoperative angiogram 
and MRI should be done for intraoperative stereotactic localization of the lesion. 
Moreover, endovascular embolisation has frequently been considered to improve 
surgical safety and to possibly magnify the pool of cAVMs amenable to safe surgical 
resection. The main goals of endovascular embolisation are elimination of arterial 
feeders (particularly those that would be challenging to access in early stages of 
surgical intervention), decrease of nidus volume that would warrant safer surgical 
resection, and management of high-risk angiographic characters such as feeding 
artery and intranidal aneurysms.
Essential steps in the resection process of AVM are wide dural opening, identi-
fication of AVM lesion, elimination of superficial feeding arteries, circumferential 
resection of the nidus with control of deep arterial pedicle, and transection of 
draining veins. When all arterial feeders to the nidus have been determined and 
coagulated, the direct venous drainage can be blocked and the nidus resected. 
Intraoperative vascular imaging, such as DSA, is beneficial to confirm complete 
nidus resection at the time of surgery. Furthermore, indocyanine green videoan-
giography with either fluorescein or indocyanine can be very useful to intraopera-
tively map the angioarchitecture of the lesions, including distinguishing arterial 
feeders from arterialized draining veins.
The surgeons should vigilantly inspect the resection bed microscopically to 
make sure that hemostasis has been achieved, during which the blood pressure 
is maintained at 15–20 mm Hg above the baseline. Oxidized cellulose (Surgicel) 
can be used to line the nidus bed, and the patient’s goal blood pressure should be 
maintained within the normal range for the first 24 hours after surgical resection.
Although the microscopic complete nidus resection has long-term durability and 
leads to abrupt elimination of hemorrhage risks, it is an invasive intervention and 
associated with neurological risks [23, 25].
6.2 Stereotactic radiosurgery (SRS)
Radiosurgery is typically reserved for the obliteration of compact cAVMs 
(less than 3 cm) in patients who are poor surgical candidates either radiographi-
cally (Spetzler-Martin grades >III) or due to existing medical comorbidities. SRS 
promotes endothelia cell proliferation, gradual, concentric vessel wall thickening, 
and ultimately luminal closure. Numerous studies about efficiency and safety 
of radiosurgery indicated that radiosurgery seems to be suitable for small-to-
moderate volume lesions (less than 12 cm3 in volume or less than 3 cm in maximum 
diameter). Furthermore, radiosurgery is best suited for injuries situated in deep 
or eloquent regions of the brain. The primary goal of SRS is the obliteration of 
cAVMs. With obliteration, the risk of hemorrhage from cAVM nidus is eliminated. 
Complete obliteration of cAVM nidus after SRS is associated with fading of cAVM-
associated epilepsy as well as improvement of nidus-associated neurological signs 
and symptoms.
Vascular Malformations of the Central Nervous System
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Most series with long-term follow-up show obliteration in 70–80% of cAVMs 
and it is achieved within 2–3 years after starting stereotactic radiosurgery (Table 3) 
[17, 20]. The time between starting radiosurgery and complete obliteration is named 
the latency period; it varies from 1 to 3 years. During this latency period, the risk 
of hemorrhage ranges between 1 and 3% per year. The outcome of radiosurgery has 
been affected by many factors such as age, nidus volume, preceding embolisation, 
and previous hemorrhage. Therefore, all these factors should be considered before 
deciding to proceed with radiosurgery.
Though preceding endovascular embolisation may shrink large nidus to a 
suitable target volume for SRS as well as eradicate high-risk characters associated 
with cAVM such as perinidal or intranidal aneurysms, it may lead to difficulties 
in precisely targeting residual nidus and reducing successful obliteration rates 
after SRS.
Radiosurgery is not entirely safe; during latency period, symptomatic changes 
secondary to radiation occur in 10 percent of the patients. However, permanent 
neurological changes are reported only in 2–3% of patients.
The main risk factors for symptomatic changes secondary to radiations are the 
location of AVM, target volume, and dose to surrounding healthy tissue (margin 
dose). The symptomatic changes secondary to radiation effect can be reduced with 
corticosteroids and bevacizumab.
Delayed cyst formation and radiation-induced neoplasia are uncommon 
although may occur after 10 years from radiosurgery [23, 26, 27].
6.3 Embolisation
Endovascular embolisation plays a crucial role in multidisciplinary approach to 
treat cAVMs. Embolisation may be considered in the following scenarios:
6.3.1 Preoperative embolization
The primary goal of preoperative embolisation is to facilitate surgical resec-
tion of cAVMs and reduce complication rates of microsurgery. It is instrumental 
in the reduction of intraoperative bleeding and postoperative complications 
such as healthy perfusion pressure breakthrough. The healthy brain tissue sur-
rounding cAVMs exposes to chronic low perfusion pressure. When the lesion is 
wholly or partially resected, these areas are suddenly subject to normal perfusion 
pressure, and their autoregulation ability may be impaired. Therefore, a sudden 
increase in perfusion pressure may lead to brain edema, delayed hemorrhage, 
and seizures. Large cAVMs should go through staged embolisation to gradually 
Study
Number Year Design Follow-up Obliteration 
rate%
Annual 
hemorrhage 
rate before 
obliteration %
Permanent 
radiation 
injury %
Ding et al 444 2013 Retrospective 86 Month 
(mean)
62 1.6 2
Starke et al 2236 2016 Multicenter 
registry
7 year 
(median)
64.7 1.1 2.7
Pollock 174 2013 Retrospective 64 month 
(mean)
78.9 Not reported 4
Table 3. 
Radio-surgical outcomes for unruptured cAVMs [23].
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reduce flow to the AVM before resection. Moreover, preoperative embolisation 
may be useful in the elimination of feeding artery pedicles that may be deep and 
not accessible [23, 28, 29].
6.3.2 Curative embolisation
The role of endovascular embolisation as a stand-alone treatment in AVM has been 
reported in small case series. The introduction of detachable-tip microcatheters plays a 
vital role in improvement of curative embolisation rates as it facilitates extended Onyx 
infusion. Small lesions with few arterial feeders are most suitable for complete curative 
embolisation. However, most of these lesions are graded as S-M grades I and II, for 
which microsurgery is considered as the best therapeutic approach. Therefore, the rela-
tive risk of curative embolisation must be weighed cautiously against this traditional 
therapeutic approach. The durability of embolic materials and the length of follow-up 
are needed to establish a complete cure. AVM recurrence after successful complete 
angiographic elimination has been reported in various case reports [23, 30, 31].
6.3.3 Before radiosurgery
Embolisation before radiosurgery is commonly used when cAVM nidus is greater 
than 3 cm in diameter to reduce the size of the nidus. However, embolisation may 
lower rates of successful obliteration, most likely due to the artifact effect of the 
radiopaque embolic interfere with targeting the lesion [23, 32].
6.3.4 Targeted embolization
Targeted embolisation is used to treat high-risk angiographic features such as 
nidal and perinidal aneurysms and arteriovenous fistulas that may lead to rupture 
of AVM [33].
6.3.5 Palliative embolization
Infrequently, cAVMs may cause focal neurological deficits as a result of vascular 
steal or local venous hypertension. In these situations, decreased venous hyper-
tension and steal by embolisation of select, high-flow feeders may improve focal 
neurological deficit and quality of life. However, there is no substantial evidence to 
support this approach and further studies are needed [23, 34, 35].
6.3.6 Complications of embolization
Stroke and ICH are the most common complications of endovascular embolisa-
tion. The ischemic stroke is most likely secondary to thromboembolic complications 
of catheterization and nontarget embolization, while ICH may occur secondary 
to vascular injury or AVM rupture. Arterial feeders’ injury and perforation occur 
when a microcatheter or wire is introduced through tiny tortuous pial arteries. 
Accidental closure of draining veins before elimination of the nidus during emboli-
zation may cause nidal rupture and ICH [23, 35, 36].
7. Conclusion
Cerebral arteriovenous malformations (cAVMs) are rare congenital disease. 
However, they are considered as a significant cause of hemorrhagic stroke in 
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children and young adults. They account for 33% of intracerebral hemorrhage 
in young patients. Although it is congenital disease, patients with cAVMs mostly 
present in their second and fourth decades of life. Intracerebral hemorrhage is the 
most common presentation of AVM patients. Imaging such as CT, MRI, and angiog-
raphy is advantageous in diagnosis, grading, risk assessment, and posttherapeutic 
follow-up. cAVMs are graded by many grading systems. However, Spetzler-Martin 
grading and supplementary Spetzler-Martin grading scales are the most important 
grading scales as they can be used to assess risk of postoperative complications and 
therapeutic outcomes. Therefore, they are beneficial in deciding best therapeutic 
approach for each patient. There are three therapeutic modalities for management 
of cAVMs. The multidisciplinary team approach is the best for management of 
cAVM patients. The surgical excision of cAVM gives definitive therapy in cAVM 
patients. Radiosurgery is a curative approach in selected cAVM patients, and 
embolisation is rarely used as a sole therapy. It is usually used as adjunctive therapy 
to microsurgery and SRS.
Author details
Adel E. Ahmed Ganaw1*, Abdulgafoor M. Tharayil1, Moad Ehfeda1,  
Mohamed Hassan Alfared2, Qazi Zeeshan1, Sohel M.G. Ahmed1, Ali Ayyad3, 
Ibrahim Naemi1, Hossam Algallie1, Nissar Shaikh1 and Nabil Shallik1
1 Anesthesiology, Intensive Care and Perioperative Medicine, Hamad General 
Hospital, Hamad Medical Corporation, Qatar
2 Radiology Department, Hamad General Hospital, Hamad Medical Corporation, 
Qatar
3 Neurosurgery Department, Hamad General Hospital, Hamad Medical 
Corporation, Qatar
*Address all correspondence to: aganaw@hamad.qa
© 2019 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
17
Cerebral Arteriovenous Malformations (cAVMs): What Is New?
DOI: http://dx.doi.org/10.5772/intechopen.90096
[1] Pandhare MN, Jyoti DB, Suresh RB. 
Acquired arteriovenous malformation 
of lip occurring as occupational hazard: 
A case report with review of literature. 
Journal of Oral and Maxillofacial 
Pathology. 2018;22(2):287
[2] Osbun JW. Arteriovenous and 
cavernous malformations. In: Handbook 
of Clinical Neurology. Vol. 143. 3rd 
series. B.V USA: Elsevier; 2017. DOI: 
10.1016/B978-0-444-63640-9.00003-5
[3] Ondra SL, Troupp H, George ED. The 
natural history of symptomatic 
arteriovenous malformations of 
the brain: A 24-year follow-up 
assessment. Journal of Neurosurgery. 
1990;73(3):387-391
[4] Lawton MT. Brain arteriovenous 
malformations. Nature Reviews Disease 
Primers. 2015;28:15008. DOI: 10.1038/
nrdp.2015.8
[5] Berman MF, Sciacca RR, Pile-
Spell-man J. The epidemiology of 
brain arteriovenous malformations. 
Neurosurgery. 2000;47:389-397
[6] Hofmeister C. Demographic, 
morphological, and clinical 
characteristics of 1289 patients with 
brain arteriovenous malformation. 
Stroke. 2000;31:1307-1310
[7] Kim H. Untreated brain 
arteriovenous malformation: Patient-
level meta-analysis of hemorrhage 
predictors. Neurology. 2014;83:590-597
[8] Willinsky RA, Lasjaunias P, 
Terbrugge K, Burrows P. Multiple  
cerebral arteriovenous malformations 
(AVMs). Review of our experience from 
203 patients with cerebral vascular 
lesions. Neuroradiology. 1990;32:207
[9] Mohr JP, Kejda-Scharler J, Pile- 
Spellman J. Diagnosis and treatment of 
arteriovenous malformations. Current 
Neurology and Neuroscience Reports. 
2013;13(2):324
[10] Hetts SW, Cooke DL, Nelson J.  
Influence of patient age on 
angioarchitecture of brain arteriovenous 
malformations. AJNR. American 
Journal of Neuroradiology. 
2014;35(7):1376-1380
[11] Stapf C, Mast H, Sciacca RR.  
Predictors of hem-orrhage in patients 
with untreated brain arteriovenous 
mal-formation. Neurology. 
2006;66(9):1350-1355
[12] Manzato LB, Vanzin JR, Frighetto L, 
Filho PM, Pedrolo E, et al. Multiple 
cerebral arteriovenous malformation: 
Report of two cases and treatment 
strategy. Journal of Neurology and 
Neurophysiology. 2017;3(1):1-4. DOI: 
10.16966/2379-7150.138
[13] Choi JH, Mast H, Sciacca RR.  
Clinical outcome after first and 
recurrent hemorrhage in patients 
with untreated brain arterio-
venous malformation. Stroke. 
2006;37:1243-1247
[14] Ding D, Starke RM, Quigg M. 
Cerebral arteriovenous malformations 
and epilepsy, part 1: Predictors 
of seizure presentation. World 
Neurosurgery. 2015;84(3):645-652
[15] July J, Wahjoepramono EJ. editors. 
Gamma knife surgery for AVM.
Neurovascular Surgery. 2019:275-283. 
DOI: 10.1007/978-981-10-8950-3-32
[16] Rajesh RU, George T, Manickam A. 
Cerebral arterio venous malformation. 
International Journal of Clinical & 
Medical Images. 2015;2(9):1-2. DOI: 
10.4172/2376-0249.1000369
[17] Zahouani T, Lopez S, Standish- 
Parkin L, et al. High grade incidental 
arteriovenous malformation. Annals 
References
Vascular Malformations of the Central Nervous System
18
of Clinical and Laboratory Research. 
2017;5:1
[18] Kim DJ, Krings T. Whole-brain 
perfusion CT patterns of brain 
arteriovenous malformations: A pilot 
study in 18 patients. AJNR. American 
Journal of Neuroradiology. 
2011;32:2061-2066
[19] Shiva Shankar JJ, Lum C. Whole 
brain perfusion on a 320-slice CT 
scanner. Indian Journal of Radiology 
and Imaging. 2011;21:209-214
[20] Roh K, Kang H, Kim I. Clinical 
application of neuroimaging with 
susceptibility weighted imaging: Review 
article. Journal of the Korean Society 
of Magnetic Resonance in Medicine. 
2014;18(4):290-302
[21] Poncea FA, Spetzler RF.  
Arteriovenous malformations: 
Classification to cure. Clinical 
Neurosurgery. 2011;58:10-12
[22] Spetzler RF, Martin NA. Proposed 
grading system for arteriovenous 
malformation. Journal of Neurosurgery. 
1986;65:476-483
[23] Derdeyn CP et al. Management of 
brain arteriovenous malformations. 
A scientific statement for healthcare 
professionals from the American 
Heart Association/American Stroke 
Association. Stroke. 2017:200-224. DOI: 
10.1161/STR. 000000000 0000134
[24] Solomon RA, Connolly ES. 
Arteriovenous malformations of the 
brain. Review article. The New England 
Journal of Medicine. 2017;376:19
[25] Barr JC, Ogilvy CS. Selection of 
treatment modalities or observation 
of arteriovenous malformations. 
Neurosurgery Clinics of North America. 
2012;23:63
[26] Pan HC, Sheehan J. Late cyst 
formation following gamma 
knife surgery of arteriovenous 
malformation. Journal of Neurosurgery. 
2005;103(suppl):124-127
[27] Starke RM, Yen CP, Chen CJ, 
Ding D, Mohila CA, Jensen ME, et al. 
An updated assessment of the risk 
of radiation-induced neoplasia 
after radiosurgery of arteriovenous 
malformations. World Neurosurgery. 
2014;82:395-401. DOI: 10.1016/j.
wneu.2013.210.02.008
[28] Gutiérrez-González R, Gil A,  
Serna C, López-Ibor L, Boto GR.  
Normal per-fusion pressure 
breakthrough phenomenon: What still 
remains unknown. British Journal of 
Neurosurgery. 2012;26:403-405. DOI: 
10.3109/02688697.2011.633637
[29] Spetzler RF, Wilson CB, 
Weinstein P, Mehdorn M, Townsend J, 
Telles D. Normal perfusion pressure 
breakthrough theory. Clinical 
Neurosurgery. 1978;25:651-672
[30] Moon K, Levitt MR, Almefty RO,  
Nakaji P, Albuquerque FC, 
Zabramski JM, et al. Safety and efficacy 
of surgical resection of unruptured 
low-grade arteriovenous malformations 
from the modern decade. Neurosurgery. 
2015;77:948-952. DOI: 10.1227/
NEU.0000000000000968
[31] Bauer AM, Bain MD, Rasmussen PA. 
Onyx resorbtion with AVM 
re-canalization after complete 
AVM obliteration. Interventional 
Neuroradiology. 2015;21:351-356. DOI: 
10.1177/1591019915581985
[32] Kano H, Kondziolka D, 
Flickinger JC, Park KJ, Iyer A, Yang HC, 
et al. Stereotactic radiosurgery for 
arteriovenous malformations after 
embolization: A case-control study. 
Journal of Neurosurgery. 2012;117:265-
275. DOI: 10.3171/2012.4.JNS111935
[33] Brown RD, Wiebers DO, 
Forbes GS. Unruptured intracranial 
19
Cerebral Arteriovenous Malformations (cAVMs): What Is New?
DOI: http://dx.doi.org/10.5772/intechopen.90096
aneu-rysms and arteriovenous 
malformations: Frequency of 
intracranial hem-orrhage and 
relationship of lesions. Journal of 
Neurosurgery. 1990;73:859-863. DOI: 
10.3171/jns.1990.73.6.0859
[34] Batjer HH, Devous MD, Seibert GB, 
Purdy PD, Ajmani AK, Delarosa M, et al. 
Intracranial arteriovenous malformation: 
Relationships between clinical and 
radiographic factors and ipsilateral steal 
severity. Neurosurgery. 1988;23:322-328
[35] Kusske JA, Kelly WA. Embolization 
and reduction of the “steal” syndrome in 
cerebral arteriovenous malformations. 
Journal of Neurosurgery. 1974;40:313-
321. DOI: 10.3171/jns.1974.40.3.0313
[36] Asadi H, Kok HK, Looby S,  
Brennan P, O’Hare A, Thornton J.  
Outcomes and complications after 
endovascular treatment of brain 
arteriovenous malformations: A 
prognostication attempt using artificial 
intelligence. World Neurosurgery. 
2016;96:562-569.e1. DOI: 10.1016/j.
wneu.2016.09.086
